A new blood test for diagnosing and monitoring infectious diseases
Drop-of-blood technology for diagnosis and therapeutic drug monitoring in patients with infectious disease
This study is working on a fast and easy blood test that helps doctors quickly understand how serious an infection is, especially for patients with conditions like COVID-19, so they can make better treatment decisions right away.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tulane University of Louisiana NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project ID | NIH-10879140 on NIH RePORTER |
What this research studies
This research aims to develop a quick and effective blood test that can assess the severity of infectious diseases at the point of care. By using a novel technique called integrated quasi-static acoustic tweezing thromboelastometry (i-QATT), the test will analyze blood coagulation without the need for complex laboratory procedures. This could allow healthcare providers to make timely treatment decisions for patients suffering from severe infections, potentially improving outcomes. The focus is particularly on conditions like COVID-19, where rapid health deterioration is often linked to coagulation issues.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients with severe infectious diseases, particularly those at risk of complications related to coagulation abnormalities.
Not a fit: Patients with mild infections or those not experiencing coagulation issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more accurate diagnosis and monitoring of infectious diseases, ultimately saving lives.
How similar studies have performed: While the approach is innovative, similar technologies have shown promise in other areas of medical diagnostics, suggesting potential for success.
Where this research is happening
New Orleans, United States
- Tulane University of Louisiana — New Orleans, United States (Active)
Researchers
- Principal investigator: Khismatullin, Damir B — Tulane University of Louisiana
- Study coordinator: Khismatullin, Damir B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.